{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:26:04Z","timestamp":1792517164745,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T00:00:00Z","timestamp":1623024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T00:00:00Z","timestamp":1623024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81601836"],"award-info":[{"award-number":["81601836"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The association between SOX14 and cancer has been reported. The aim of this study was to identify and validate the potential value of SOX14 methylation in the early detection of cervical cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>First, we extracted the data for SOX14 methylation and expression within cervical cancer from The Cancer Genome Atlas (TCGA) database and analysed them via UALCAN, Wanderer, MEXPRESS and LinkedOmics. Subsequently, according to the bioinformatics findings, primers and probes were designed for the most significantly differentiated methylation CpG site and synthesized for methylation-specific PCR (MSP) and quantitative methylation-specific PCR (QMSP) to verify SOX14 methylation in both cervical tissuses and liquid-based cell samples. Eventually, the clinical diagnostic efficacy of SOX14 methylation in the normal, cervical intraepithelial neoplasia, and cancer groups was analysed by ROC<jats:sup>AUC<\/jats:sup>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Pooled analysis demonstrated that SOX14 methylation levels were significantly increased in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) compared to normal tissues (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Both the verification and validation cohorts indicated that the methylation level and the positive rate of SOX14 gradually increased with increasing severity from normal to cancer samples (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01). When the cut-off value was set as 128.45, the sensitivity and specificity of SOX14 hypermethylation in the diagnosis of cervical cancer were 94.12 and 86.46%, respectively. When taken as a screening biomarker (&gt;CINII), the sensitivity was 74.42% and the specificity was 81.48%, with a cut-off value of 10.37.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>SOX14 hypermethylation is associated with cervical cancer and has the potential to be a molecular biomarker for the screening and early diagnosis of cervical cancer.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12885-021-08406-2","type":"journal-article","created":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T19:03:27Z","timestamp":1623092607000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["SOX14 hypermethylation as a tumour biomarker in cervical cancer"],"prefix":"10.1186","volume":"21","author":[{"given":"Jing","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjuan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3502-5446","authenticated-orcid":false,"given":"Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,7]]},"reference":[{"issue":"3","key":"8406_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"8406_CR2","doi-asserted-by":"publisher","first-page":"319","DOI":"10.22034\/APJCP.2018.19.2.319","volume":"19","author":"AD Shrestha","year":"2018","unstructured":"Shrestha AD, Neupane D, Vedsted P, Kallestrup P. Cervical Cancer prevalence, incidence and mortality in low and middle income countries: a systematic review. Asian Pac J Cancer Prev. 2018;19(2):319\u201324. https:\/\/doi.org\/10.22034\/APJCP.2018.19.2.319.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"Suppl 7","key":"8406_CR3","doi-asserted-by":"publisher","first-page":"H32","DOI":"10.1016\/j.vaccine.2013.02.071","volume":"31","author":"F Bray","year":"2013","unstructured":"Bray F, Lortet-Tieulent J, Znaor A, Brotons M, Poljak M, Arbyn M. Patterns and trends in human papillomavirus-related diseases in central and Eastern Europe and Central Asia. Vaccine. 2013;31(Suppl 7):H32\u201345. https:\/\/doi.org\/10.1016\/j.vaccine.2013.02.071.","journal-title":"Vaccine."},{"issue":"4","key":"8406_CR4","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.ajog.2015.10.147","volume":"214","author":"BF Lees","year":"2016","unstructured":"Lees BF, Erickson BK, Huh WK. Cervical cancer screening: evidence behind the guidelines. Am J Obstet Gynecol. 2016;214(4):438\u201343. https:\/\/doi.org\/10.1016\/j.ajog.2015.10.147.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"8406_CR5","doi-asserted-by":"publisher","first-page":"184 e1","DOI":"10.1016\/j.ajog.2012.11.020","volume":"208","author":"JT Cox","year":"2013","unstructured":"Cox JT, Castle PE, Behrens CM, Sharma A, Wright TC Jr, Cuzick J, et al. Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16\/18: results from the ATHENA HPV study. Am J Obstet Gynecol. 2013;208(3):184 e1\u2013e11.","journal-title":"Am J Obstet Gynecol"},{"issue":"16","key":"8406_CR6","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1056\/NEJMoa071430","volume":"357","author":"MH Mayrand","year":"2007","unstructured":"Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med. 2007;357(16):1579\u201388. https:\/\/doi.org\/10.1056\/NEJMoa071430.","journal-title":"N Engl J Med"},{"key":"8406_CR7","doi-asserted-by":"publisher","unstructured":"Dehn D, Torkko KG, Shroyer KR. Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma. Cancer Cytopathol 2007;111(1):1\u201314, 1, DOI: https:\/\/doi.org\/10.1002\/cncr.22425.","DOI":"10.1002\/cncr.22425"},{"issue":"1","key":"8406_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1172\/JCI69740","volume":"124","author":"DJ Weisenberger","year":"2014","unstructured":"Weisenberger DJ. Characterizing DNA methylation alterations from The Cancer Genome Atlas. J Clin Invest. 2014;124(1):17\u201323. https:\/\/doi.org\/10.1172\/JCI69740.","journal-title":"J Clin Invest"},{"key":"8406_CR9","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.semcancer.2019.03.004","volume":"67","author":"D Grimm","year":"2020","unstructured":"Grimm D, Bauer J, Wise P, Kruger M, Simonsen U, Wehland M, et al. The role of SOX family members in solid tumours and metastasis. Semin Cancer Biol. 2020;67:122\u201353. https:\/\/doi.org\/10.1016\/j.semcancer.2019.03.004.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"8406_CR10","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.ygyno.2013.07.111","volume":"131","author":"YW Lin","year":"2013","unstructured":"Lin YW, Tsao CM, Yu PN, Shih YL, Lin CH, Yan MD. SOX1 suppresses cell growth and invasion in cervical cancer. Gynecol Oncol. 2013;131(1):174\u201381. https:\/\/doi.org\/10.1016\/j.ygyno.2013.07.111.","journal-title":"Gynecol Oncol"},{"issue":"7","key":"8406_CR11","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/apm.12543","volume":"124","author":"L Song","year":"2016","unstructured":"Song L, Liu D, He J, Wang X, Dai Z, Zhao Y, et al. SOX1 inhibits breast cancer cell growth and invasion through suppressing the Wnt\/\u2212catenin signaling pathway. Apmis. 2016;124(7):547\u201355. https:\/\/doi.org\/10.1111\/apm.12543.","journal-title":"Apmis"},{"issue":"6","key":"8406_CR12","doi-asserted-by":"publisher","first-page":"4603","DOI":"10.1007\/s13277-015-3107-x","volume":"36","author":"N Li","year":"2015","unstructured":"Li N, Li S. Epigenetic inactivation of SOX1 promotes cell migration in lung cancer. Tumor Biol. 2015;36(6):4603\u201310. https:\/\/doi.org\/10.1007\/s13277-015-3107-x.","journal-title":"Tumor Biol"},{"key":"8406_CR13","doi-asserted-by":"publisher","unstructured":"Garcia I, Aldaregia J, Vicentic JM, Aldaz P, Moreno-Cugnon L, Torres-Bayona S, et al. Oncogenic activity of SOX1 in glioblastoma. Sci Rep. 2017;7(1). https:\/\/doi.org\/10.1038\/srep46575.","DOI":"10.1038\/srep46575"},{"issue":"5","key":"8406_CR14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41419-020-2513-1","volume":"11","author":"X-X Lei","year":"2020","unstructured":"Lei X-X, Liu Y, Wang J-X, Cai Q, Yan M, He H-P, et al. SOX1 promotes differentiation of nasopharyngeal carcinoma cells by activating retinoid metabolic pathway. Cell Death Dis. 2020;11(5):331.","journal-title":"Cell Death Dis"},{"issue":"15","key":"8406_CR15","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.2174\/1389450117666160502145311","volume":"17","author":"J Li","year":"2016","unstructured":"Li J, Shen J, Wang K, Hornicek F, Duan Z. The roles of sox family genes in sarcoma. Curr Drug Targets. 2016;17(15):1761\u201372. https:\/\/doi.org\/10.2174\/1389450117666160502145311.","journal-title":"Curr Drug Targets"},{"issue":"6","key":"8406_CR16","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1002\/cam4.661","volume":"5","author":"E Long","year":"2016","unstructured":"Long E, Ilie M, Bence C, Butori C, Selva E, Lalvee S, et al. High expression of TRF2, SOX10, and CD10 in circulating tumor microemboli detected in metastatic melanoma patients. A potential impact for the assessment of disease aggressiveness. Cancer Med-Us. 2016;5(6):1022\u201330. https:\/\/doi.org\/10.1002\/cam4.661.","journal-title":"Cancer Med-Us"},{"issue":"25","key":"8406_CR17","doi-asserted-by":"publisher","first-page":"3928","DOI":"10.1182\/blood-2014-06-580993","volume":"125","author":"CH Man","year":"2015","unstructured":"Man CH, Fung TK, Wan H, Cher CY, Fan A, Ng N, et al. Suppression of SOX7 by DNA methylation and its tumor suppressor function in acute myeloid leukemia. Blood. 2015;125(25):3928\u201336. https:\/\/doi.org\/10.1182\/blood-2014-06-580993.","journal-title":"Blood."},{"issue":"3","key":"8406_CR18","doi-asserted-by":"publisher","first-page":"462","DOI":"10.20892\/j.issn.2095-3941.2019.0062","volume":"16","author":"J Hu","year":"2019","unstructured":"Hu J, Li K, Li Z, Gao C, Guo F, Wang Y, et al. Sex-determining region Y box-containing genes: regulators and biomarkers in gynecological cancers. Cancer Biology & Medicine. 2019;16(3):462\u201374. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2019.0062.","journal-title":"Cancer Biology & Medicine"},{"issue":"5","key":"8406_CR19","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1172\/JCI78815","volume":"126","author":"F Ma","year":"2016","unstructured":"Ma F, Ye H, He HH, Gerrin SJ, Chen S, Tanenbaum BA, et al. SOX9 drives WNT pathway activation in prostate cancer. J Clin Investig. 2016;126(5):1745\u201358. https:\/\/doi.org\/10.1172\/JCI78815.","journal-title":"J Clin Investig"},{"issue":"9","key":"8406_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0184686","volume":"12","author":"S Deb","year":"2017","unstructured":"Deb S, Stanisavljevic D, Petrovic I, Vukovic V, Schwirtlich M, Gredic M, et al. SOX14 activates the p53 signaling pathway and induces apoptosis in a cervical carcinoma cell line. PLoS One. 2017;12(9):e0184686.","journal-title":"PLoS One"},{"issue":"2","key":"8406_CR21","first-page":"1698","volume":"8","author":"F Li","year":"2015","unstructured":"Li F, Wang TR, Tang SJ. SOX14 promotes proliferation and invasion of cervical cancer cells through Wnt\/beta-catenin pathway. Int J Clin Exp Patho. 2015;8(2):1698\u2013704.","journal-title":"Int J Clin Exp Patho"},{"key":"8406_CR22","doi-asserted-by":"crossref","unstructured":"Tong WG, Wierda WG, Lin E, Kuang SQ, Bekele BN, Estrov Z, et al. Genome-wide DNA methylation profiling of chronic lymphocytic leukemia allows identification of epigenetically repressed molecular pathways with clinical impact. Epigenetics-Us. 2010;5(6):499\u2013508.","DOI":"10.4161\/epi.5.6.12179"},{"issue":"8","key":"8406_CR23","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19(8):649\u201358. https:\/\/doi.org\/10.1016\/j.neo.2017.05.002.","journal-title":"Neoplasia."},{"issue":"1","key":"8406_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13072-015-0014-8","volume":"8","author":"A Diez-Villanueva","year":"2015","unstructured":"Diez-Villanueva A, Mallona I, Peinado MA. Wanderer, an interactive viewer to explore DNA methylation and gene expression data in human cancer. Epigenetics Chromatin. 2015;8(1):22. https:\/\/doi.org\/10.1186\/s13072-015-0014-8.","journal-title":"Epigenetics Chromatin"},{"issue":"W1","key":"8406_CR25","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"ZF Tang","year":"2019","unstructured":"Tang ZF, Kang BX, Li CW, Chen TX, Zhang ZM. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47(W1):W556\u2013W60. https:\/\/doi.org\/10.1093\/nar\/gkz430.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"8406_CR26","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1186\/s12864-015-1847-z","volume":"16","author":"A Koch","year":"2015","unstructured":"Koch A, De Meyer T, Jeschke J, Van Criekinge W. MEXPRESS: visualizing expression, DNA methylation and clinical TCGA data. BMC Genomics. 2015;16(1):636. https:\/\/doi.org\/10.1186\/s12864-015-1847-z.","journal-title":"BMC Genomics"},{"issue":"D1","key":"8406_CR27","doi-asserted-by":"publisher","first-page":"D956","DOI":"10.1093\/nar\/gkx1090","volume":"46","author":"SV Vasaikar","year":"2018","unstructured":"Vasaikar SV, Straub P, Wang J, Zhang B. LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. 2018;46(D1):D956\u2013D63. https:\/\/doi.org\/10.1093\/nar\/gkx1090.","journal-title":"Nucleic Acids Res"},{"issue":"17","key":"8406_CR28","doi-asserted-by":"publisher","first-page":"4598","DOI":"10.1158\/1078-0432.CCR-13-3380","volume":"20","author":"Z Liu","year":"2014","unstructured":"Liu Z, Zhang J, Gao Y, Pei L, Zhou J, Gu L, et al. Large-scale characterization of DNA methylation changes in human gastric carcinomas with and without metastasis. Clin Cancer Res. 2014;20(17):4598\u2013612. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-3380.","journal-title":"Clin Cancer Res"},{"issue":"12","key":"8406_CR29","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","volume":"17","author":"JJM van Dongen","year":"2003","unstructured":"van Dongen JJM, Langerak AW, Bruggemann M, Evans PAS, Hummel M, Lavender FL, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 concerted action BMH4-CT98-3936. Leukemia. 2003;17(12):2257\u2013317. https:\/\/doi.org\/10.1038\/sj.leu.2403202.","journal-title":"Leukemia"},{"issue":"5","key":"8406_CR30","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1158\/1541-7786.289.2.5","volume":"2","author":"N Reesink-Peters","year":"2004","unstructured":"Reesink-Peters N, Wisman GBA, Jeronimo C, Tokumaru CY, Cohen Y, Dong SM, et al. Detecting cervical cancer by quantitative promoter hypermethylation assay on cervical scrapings: a feasibility study. Mol Cancer Res. 2004;2(5):289\u201395.","journal-title":"Mol Cancer Res"},{"issue":"12","key":"8406_CR31","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1080\/15592294.2020.1777666","volume":"15","author":"B Griess","year":"2020","unstructured":"Griess B, Klinkebiel D, Kueh A, Desler M, Cowan K, Fitzgerald M, et al. Association ofSOD3promoter DNA methylation with its down-regulation in breast carcinomas. Epigenetics-Us. 2020;15(12):1325\u201335. https:\/\/doi.org\/10.1080\/15592294.2020.1777666.","journal-title":"Epigenetics-Us"},{"issue":"4","key":"8406_CR32","doi-asserted-by":"publisher","first-page":"4377","DOI":"10.1007\/s11033-019-04892-7","volume":"46","author":"PP Li","year":"2019","unstructured":"Li PP, Liu J, Li J, Liu PJ. DNA methylation of CRB3 is a prognostic biomarker in clear cell renal cell carcinoma. Mol Biol Rep. 2019;46(4):4377\u201383. https:\/\/doi.org\/10.1007\/s11033-019-04892-7.","journal-title":"Mol Biol Rep"},{"issue":"7","key":"8406_CR33","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1089\/gtmb.2020.0009","volume":"24","author":"JB Ma","year":"2020","unstructured":"Ma JB, Bai JY, Zhang HB, Gu LJ, He DL, Guo P. Downregulation of collagen COL4A6 is associated with prostate Cancer progression and metastasis. Genet Test Mol Bioma. 2020;24(7):399\u2013408. https:\/\/doi.org\/10.1089\/gtmb.2020.0009.","journal-title":"Genet Test Mol Bioma"},{"key":"8406_CR34","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.3389\/fgene.2019.01150","volume":"10","author":"WJ Locke","year":"2019","unstructured":"Locke WJ, Guanzon D, Ma C, Liew YJ, Duesing KR, Fung KYC, et al. DNA methylation Cancer biomarkers: translation to the clinic. Front Genet. 2019;10:1150. https:\/\/doi.org\/10.3389\/fgene.2019.01150.","journal-title":"Front Genet"},{"key":"8406_CR35","doi-asserted-by":"publisher","first-page":"100170","DOI":"10.1016\/j.pvr.2019.100170","volume":"8","author":"K Canfell","year":"2019","unstructured":"Canfell K. Towards the global elimination of cervical cancer. Papillomavirus Res (Amsterdam, Netherlands). 2019;8:100170.","journal-title":"Papillomavirus Res (Amsterdam, Netherlands)"},{"key":"8406_CR36","doi-asserted-by":"crossref","unstructured":"Rebolj M, Rimmer J, Denton K, Tidy J, Mathews C, Ellis K, et al. Primary cervical screening with high risk human papillomavirus testing: observational study. Bmj-Br Med J. 2019;364:l240.","DOI":"10.1136\/bmj.l240"},{"issue":"3","key":"8406_CR37","first-page":"257","volume":"39","author":"TKY Tay","year":"2017","unstructured":"Tay TKY, Lim KL, Hilmy MH, Thike AA, Goh ST, Song LH, et al. Comparison of the sensitivity and specificity of p16\/Ki-67 dual staining and HPV DNA testing of abnormal cervical cytology in the detection of histology proven cervical intraepithelial neoplasia grade 2 and above (CIN 2+). Malays J Pathol. 2017;39(3):257\u201365.","journal-title":"Malays J Pathol"},{"issue":"6","key":"8406_CR38","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1634\/theoncologist.2014-0303","volume":"20","author":"B Wang","year":"2015","unstructured":"Wang B, He M, Chao A, Engelgau MM, Saraiya M, Wang L, et al. Cervical Cancer screening among adult women in China, 2010. Oncologist. 2015;20(6):627\u201334. https:\/\/doi.org\/10.1634\/theoncologist.2014-0303.","journal-title":"Oncologist."},{"issue":"1","key":"8406_CR39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13072-018-0191-3","volume":"11","author":"RC Slieker","year":"2018","unstructured":"Slieker RC, Relton CL, Gaunt TR, Slagboom PE, Heijmans BT. Age-related DNA methylation changes are tissue-specific with ELOVL2 promoter methylation as exception. Epigenet Chromatin. 2018;11(1):25. https:\/\/doi.org\/10.1186\/s13072-018-0191-3.","journal-title":"Epigenet Chromatin"},{"key":"8406_CR40","doi-asserted-by":"publisher","unstructured":"Lin X, Tan JYL, Teh AL, et al. Cell type-specific DNA methylation in neonatal cord tissue and cord blood: a 850K-reference panel and comparison of cell types. Epigenetics. 2018;13(9):941\u201358. https:\/\/doi.org\/10.1080\/15592294.2018.1522929.","DOI":"10.1080\/15592294.2018.1522929"},{"issue":"1","key":"8406_CR41","doi-asserted-by":"publisher","first-page":"13347","DOI":"10.1038\/s41598-019-50005-6","volume":"9","author":"J Iwabu","year":"2019","unstructured":"Iwabu J, Yamashita S, Takeshima H, Kishino T, Takahashi T, Oda I, et al. FGF5 methylation is a sensitivity marker of esophageal squamous cell carcinoma to definitive chemoradiotherapy. Sci Rep. 2019;9(1):13347. https:\/\/doi.org\/10.1038\/s41598-019-50005-6.","journal-title":"Sci Rep"},{"key":"8406_CR42","doi-asserted-by":"crossref","unstructured":"Wu N-YY, Zhang X, Chu T, Zhu S, Deng Y, Zhou Y, et al. High methylation of ZNF582 in cervical adenocarcinoma affects radiosensitivity and prognosis. Ann Transl Med. 2019;7(14):328.","DOI":"10.21037\/atm.2019.06.15"},{"key":"8406_CR43","doi-asserted-by":"crossref","unstructured":"Pils D, Steindl E, Bachmayr-Heyda A, Dekan S, Aust S. A Global Gene Body Methylation Measure Correlates Independently with Overall Survival in Solid Cancer Types. Cancers. 2020;12(8):2257.","DOI":"10.3390\/cancers12082257"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08406-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-08406-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08406-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T06:43:09Z","timestamp":1672382589000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-08406-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,7]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8406"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-08406-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,7]]},"assertion":[{"value":"6 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Ethics Committee of Tianjin Medical University, and all patients gave informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"675"}}